Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study on the Consistency Between Patient-Derived Pancreatic Cancer Organoid-on-a-Chip Drug Sensitivity Test Results and Clinical Chemotherapy Efficacy

NCT07683845 is registered in ClinicalTrials.gov with Beijing Daxiang Biotech Co., Ltd as lead sponsor.

NCT NCT07683845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07683845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study on the Consistency Between Patient-Derived Pancreatic Cancer Organoid-on-a-Chip Drug Sensitivity Test Results and Clinical Chemotherapy Efficacy
Lead sponsor
Beijing Daxiang Biotech Co., Ltd
Phase
Observational
Overall status
Recruiting
Start date
February 20, 2026
Completion date
February 20, 2028
Enrollment
164 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic ductal adenocarcinoma (pdac)